goBalto Announces Latest Release of goBalto Activate

SAN FRANCISCO, Jan. 13, 2015 /PRNewswire/ — goBalto, Inc., the leading
provider of cloud-based clinical study startup solutions, today announced the release
of its latest version of goBalto Activate, its flagship study startup platform. With this
release, goBalto is changing the way clinical study sponsors and contract research
organizations (CROs) start clinical studies around the world.

goBalto Announces Latest Release of goBalto Activate Read More »

Expedia CruiseShipCenters Completes Transactions 10x Faster with DocuSign

VANCOUVER, B.C.— January 13, 2015 — Expedia® CruiseShipCenters®, a retail
travel franchise owned by Expedia® Inc., today announced it has rolled out
DocuSign, Inc.’s Digital Transaction Management (DTM) platform and industryleading eSignature solution integrated with Microsoft Office 365 to its nearly 200
franchise partners across North America.

Expedia CruiseShipCenters Completes Transactions 10x Faster with DocuSign Read More »

MerLion’s Finafloxacin Shows Positive Phase 2 Results in Complicated Urinary Tract Infections

Singapore, 8 January 2015 – MerLion Pharmaceuticals (“MerLion”), a biopharmaceutical company
based in Singapore and Berlin, today announced positive results from a phase 2 trial with finafloxacin,
conducted in Europe, treating patients hospitalized with complicated urinary tract infections (cUTI),
including a high proportion with pyelonephritis.

MerLion’s Finafloxacin Shows Positive Phase 2 Results in Complicated Urinary Tract Infections Read More »